B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction

被引:383
作者
Richards, AM
Nicholls, MG
Espiner, EA
Lainchbury, JG
Troughton, RW
Elliott, J
Frampton, C
Turner, J
Crozier, IG
Yandle, TG
机构
[1] Christchurch Hosp, Dept Nucl Med, Christchurch, New Zealand
[2] Christchurch Hosp, Dept Cardiol, Christchurch, New Zealand
关键词
coronary disease; natriuretic peptides; heart failure;
D O I
10.1161/01.CIR.0000070953.76250.B9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-A recent landmark report has demonstrated that plasma B-type natriuretic peptide (BNP) measured in acute coronary syndromes independently predicts mortality, heart failure, and new myocardial infarction. After acute cardiac injury, left ventricular ejection fraction (LVEF) is also of prognostic significance and plays a major role in determining the therapeutic response. Methods and Results-The present report is the first from a substantial (n = 666) cohort of patients with acute myocardial infarction to test the prognostic utility of concurrent measurements of BNP, amino-terminal BNP (N-BNP), norepinephrine, and radionuclide LVEF. The B-type peptides and LVEF were predictors of death, heart failure, and new myocardial infarction (all P < 0.001) independent of patient age, gender, previous myocardial infarction, antecedent hypertension or diabetes, previous heart failure, plasma norepinephrine, creatinine, cholesterol, drug therapy, and coronary revascularization procedures. The combination of N-BNP (or BNP) with LVEF substantially improved risk stratification beyond that provided by either alone. Elevated N-BNP (or BNP) predicted new myocardial infarction only in patients with LVEF < 40%. LVEF < 40% coupled to N-BNP over the group median conferred substantial 3-year risks of death, heart failure, and new myocardial infarction of 37%, 18%, and 26%, respectively. N-BNP and BNP were equivalent prognostic markers for these clinical outcomes. Conclusions-Plasma N-BNP (or BNP) and LVEF are complementary independent predictors of major adverse events on follow-up after myocardial infarction. Combined measurement provides risk stratification substantially better than that provided by either alone.
引用
收藏
页码:2786 / 2792
页数:7
相关论文
共 33 条
  • [11] N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation
    Jernberg, T
    Stridsberg, M
    Venge, P
    Lindahl, B
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (03) : 437 - 445
  • [12] Lechat P, 1999, LANCET, V353, P9
  • [13] MacMahon S, 1997, LANCET, V349, P375
  • [14] Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population
    McDonagh, TA
    Cunningham, AD
    Morrison, CE
    McMurray, JJV
    Ford, I
    Morton, JJ
    Dargie, HJ
    [J]. HEART, 2001, 86 (01) : 21 - 26
  • [15] PLASMA BRAIN NATRIURETIC PEPTIDE AS AN INDICATOR FOR ANGIOTENSIN-CONVERTING-ENZYME INHIBITION AFTER MYOCARDIAL-INFARCTION
    MOTWANI, JG
    MCALPINE, H
    KENNEDY, N
    STRUTHERS, AD
    [J]. LANCET, 1993, 341 (8853) : 1109 - 1113
  • [16] NICKLAS JM, 1992, NEW ENGL J MED, V327, P685
  • [17] N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes
    Omland, T
    Persson, A
    Ng, L
    O'Brien, R
    Karlsson, T
    Herlitz, J
    Hartford, M
    Caidahl, K
    [J]. CIRCULATION, 2002, 106 (23) : 2913 - 2918
  • [18] Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction - Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
    Omland, T
    Aakvaag, A
    Bonarjee, VVS
    Caidahl, K
    Lie, RT
    Nilsen, DWT
    Sundsfjord, JA
    Dickstein, K
    [J]. CIRCULATION, 1996, 93 (11) : 1963 - 1969
  • [19] Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes
    Omland, T
    de Lemos, JA
    Morrow, DA
    Antman, EN
    Cannon, CP
    Hall, C
    Braunwald, E
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (04) : 463 - +
  • [20] The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
    Packer, M
    Bristow, MR
    Cohn, JN
    Colucci, WS
    Fowler, MB
    Gilbert, EM
    Shusterman, NH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21) : 1349 - 1355